Mercom Capital Group September 9, 2021
Staff

The financial terms of the acquisition were not disclosed

Recuro Health, a digital virtual care platform, acquired MyLifeIQ, an epigenetics and precision medicine platform. The terms of the acquisition were not disclosed.

MyLifeIQ precision medicine platform captures data and delivers the uniqueness of each person, pulling together the variables involved in health, including DNA, wearable data, and lifestyle assessments.

Recently, Recuro Health, announced the acquisition of SupDoc, an AI-enabled virtual health solution for care delivery. The financial terms of the acquisition were not disclosed.

Recuro offers a cloud-based virtual care platform with a curated suite of digital solutions – from primary care and behavioral health to at-home testing and genetic screening. According to the company, these digital solutions allow patients...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health IT, Mergers & Acquisitions / JV, Pharma / Biotech, Precision Medicine, Technology, Telehealth, Trends
How Remote Patient Monitoring and AI Personalize Care
Digital Platforms Streamline Medication Access and Delivery
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say
Novel tech to answer nature’s call: Smartphone app provides real-time bladder data for seniors who need assistance
25 best healthcare software companies, per Healthcare Technology Report

Share This Article